HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases globally. The company is headquartered in Mountain View, California.
| Revenue (TTM) | $191.42M |
| Gross Profit (TTM) | $149.42M |
| EBITDA | $-67.19M |
| Operating Margin | -41.90% |
| Return on Equity | -135.30% |
| Return on Assets | -16.20% |
| Revenue/Share (TTM) | $3.38 |
| Book Value | $3.32 |
| Price-to-Book | 8.90 |
| Price-to-Sales (TTM) | 13.29 |
| EV/Revenue | 12.6 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.30% |
| Shares Outstanding | $86.24M |
| Float | $66.26M |
| % Insiders | 5.16% |
| % Institutions | 77.05% |
Volatility is currently expanding